Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Huiyan Luo

17PUBLICATIONS
116CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

Sort by Publication Date:
|Mar 02, 2026
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy.

Zheng-Yu Qian, Yuqing Deng, Mian Xi

|Dec 01, 2025
Targeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axis.

Lu-Ping Yang, Jia-Qian Huang, Chiu-Wing Yeung

|Oct 30, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.

Hui-Yan Luo, Wei Wei, Pansong Li

|Apr 27, 2025
Nuclear mitochondrial acetyl-CoA acetyltransferase 1 orchestrates natural killer cell-dependent antitumor immunity in colorectal cancer.

Chen Wei, Kun Liao, Hao-Jie Chen

|Mar 21, 2025
Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD-1 and VEGF, in Chinese Patients With Advanced Solid Tumors.

Fenghua Wang, Xiaoli Wei, Yulong Zheng

|Dec 15, 2024
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.

Miao-Zhen Qiu, Yuxian Bai, Jufeng Wang

Pageof 3

Frequent Collaborators

14 joint publications

Ruihua Xu

5 joint publications

Zhaolei Zeng

4 joint publications

Qi Zhao

4 joint publications

Zexian Liu

3 joint publications

Miao-Zheng Qiu

3 joint publications

Zhi-Wei Zhou

2 joint publications

Feng Wang

2 joint publications

Ming-Ming He

2 joint publications

Jian Xiao

2 joint publications

Wei-Jia Fang

Frequent Collaborators

14 joint publications

Ruihua Xu

5 joint publications

Zhaolei Zeng

4 joint publications

Qi Zhao

4 joint publications

Zexian Liu

Top Related Videos

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on : Apr 05, 2024

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on : Sep 18, 2020

6.0K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on : Jun 08, 2019

9.1K
See more related videos

Top Related Videos

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on : Apr 05, 2024

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on : Sep 18, 2020

6.0K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on : Jun 08, 2019

9.1K
See more related videos